Capdevila D, Rondon J, Edmonds K, Rocchio J, Villarruel Dujovne M, Giedroc D
Chem Rev. 2024; 124(24):13574-13659.
PMID: 39658019
PMC: 11672702.
DOI: 10.1021/acs.chemrev.4c00264.
Liu Q, Huang B, Guiberson N, Chen S, Zhu D, Ma G
Sci Adv. 2024; 10(47):eadn5417.
PMID: 39576856
PMC: 11584015.
DOI: 10.1126/sciadv.adn5417.
Xiong Y, Yu J
Trends Mol Med. 2024; 30(10):982-996.
PMID: 39153957
PMC: 11466701.
DOI: 10.1016/j.molmed.2024.07.003.
Kmiecik M, Micheletti S, Coker D, Heilbron K, Shi J, Stagaman K
Brain. 2024; 147(6):1996-2008.
PMID: 38804604
PMC: 11146432.
DOI: 10.1093/brain/awae073.
Park A, Leney-Greene M, Lynberg M, Gabrielski J, Xu X, Schwarz B
Nat Immunol. 2024; 25(2):282-293.
PMID: 38172257
PMC: 11151279.
DOI: 10.1038/s41590-023-01691-y.
Allosteric control of dynamin-related protein 1 through a disordered C-terminal Short Linear Motif.
Perez-Jover I, Rochon K, Hu D, Mahajan M, Madan Mohan P, Santos-Perez I
Nat Commun. 2024; 15(1):52.
PMID: 38168038
PMC: 10761769.
DOI: 10.1038/s41467-023-44413-6.
The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications.
Szewczyk-Roszczenko O, Roszczenko P, Shmakova A, Finiuk N, Holota S, Lesyk R
Cells. 2023; 12(18).
PMID: 37759535
PMC: 10527932.
DOI: 10.3390/cells12182312.
Leucine-rich repeat kinase 2 at a glance.
Zhu C, Herbst S, Lewis P
J Cell Sci. 2023; 136(17).
PMID: 37698513
PMC: 10508695.
DOI: 10.1242/jcs.259724.
Allosteric control of dynamin-related protein 1-catalyzed mitochondrial fission through a conserved disordered C-terminal Short Linear Motif.
Perez-Jover I, Rochon K, Hu D, Madan Mohan P, Santos-Perez I, Ormaetxea Gisasola J
Res Sq. 2023; .
PMID: 37503116
PMC: 10371074.
DOI: 10.21203/rs.3.rs-3161608/v1.
SynDLP is a dynamin-like protein of Synechocystis sp. PCC 6803 with eukaryotic features.
Gewehr L, Junglas B, Jilly R, Franz J, Zhu W, Weidner T
Nat Commun. 2023; 14(1):2156.
PMID: 37059718
PMC: 10104851.
DOI: 10.1038/s41467-023-37746-9.
Identification of C. elegans ASNA-1 domains and tissue requirements that differentially influence platinum sensitivity and growth control.
Raj D, Podraza-Farhanieh A, Gallego P, Kao G, Naredi P
PLoS Genet. 2022; 18(12):e1010538.
PMID: 36480541
PMC: 9803280.
DOI: 10.1371/journal.pgen.1010538.
Membrane fusion by atlastin does not require GTP hydrolysis.
Crosby D, Lee T
Mol Biol Cell. 2022; 33(14):br23.
PMID: 36129776
PMC: 9727788.
DOI: 10.1091/mbc.E22-05-0164.
Role of Clathrin and Dynamin in Clathrin Mediated Endocytosis/Synaptic Vesicle Recycling and Implications in Neurological Diseases.
Prichard K, OBrien N, Murcia S, Baker J, McCluskey A
Front Cell Neurosci. 2022; 15:754110.
PMID: 35115907
PMC: 8805674.
DOI: 10.3389/fncel.2021.754110.
The Structural Biology of Septins and Their Filaments: An Update.
Cavini I, Leonardo D, Rosa H, Castro D, Pereira H, Valadares N
Front Cell Dev Biol. 2021; 9:765085.
PMID: 34869357
PMC: 8640212.
DOI: 10.3389/fcell.2021.765085.
Substrate induced generation of transient self-assembled catalytic systems.
Afrose S, Ghosh C, Das D
Chem Sci. 2021; 12(44):14674-14685.
PMID: 34820083
PMC: 8597835.
DOI: 10.1039/d1sc03492h.
Reconstitution of human atlastin fusion activity reveals autoinhibition by the C terminus.
Crosby D, Mikolaj M, Nyenhuis S, Bryce S, Hinshaw J, Lee T
J Cell Biol. 2021; 221(2).
PMID: 34817557
PMC: 8624677.
DOI: 10.1083/jcb.202107070.
A conserved guided entry of tail-anchored pathway is involved in the trafficking of a subset of membrane proteins in Plasmodium falciparum.
Kumar T, Maitra S, Rahman A, Bhattacharjee S
PLoS Pathog. 2021; 17(11):e1009595.
PMID: 34780541
PMC: 8629386.
DOI: 10.1371/journal.ppat.1009595.
A structural model of a Ras-Raf signalosome.
Mysore V, Zhou Z, Ambrogio C, Li L, Kapp J, Lu C
Nat Struct Mol Biol. 2021; 28(10):847-857.
PMID: 34625747
PMC: 8643099.
DOI: 10.1038/s41594-021-00667-6.
Markov State Models and Molecular Dynamics Simulations Provide Understanding of the Nucleotide-Dependent Dimerization-Based Activation of LRRK2 ROC Domain.
Li X, Qi Z, Ni D, Lu S, Chen L, Chen X
Molecules. 2021; 26(18).
PMID: 34577121
PMC: 8467336.
DOI: 10.3390/molecules26185647.
LRRK2 Targeting Strategies as Potential Treatment of Parkinson's Disease.
Wojewska D, Kortholt A
Biomolecules. 2021; 11(8).
PMID: 34439767
PMC: 8392603.
DOI: 10.3390/biom11081101.